:BA1 rdf:type :Drug ;
    rdfs:label "BA 1" ;
    :affectsMolecule :N2CyanoethyleneUrea ;
    :hasSideEffect :NegligibleLethality ;
    :usedFor :DSCarcinosarcoma ;
    :interactsWith :Ifosfamide ;
    :involvedIn :ImmunoStimulationPathway ;
    :targetsGene :LeucocyteGene ;
    :relatedTo :TumorInhibitionMechanism .

:Ifosfamide rdf:type :Drug ;
    rdfs:label "Ifosfamide" ;
    :usedFor :DSCarcinosarcoma ;
    :hasSideEffect :Lethality18Percent ;
    :involvedIn :CancerTreatmentPathway ;
    :targetsGene :LeucocyteGene ;
    :relatedTo :TumorInhibitionMechanism .

:DSCarcinosarcoma rdf:type :Disease ;
    rdfs:label "DS Carcinosarcoma" ;
    :leadsToSymptom :RecoveryRate25Percent, :RecoveryRate40Percent ;
    :associatedWithPathway :TumorInhibitionPathway .

:NegligibleLethality rdf:type :SideEffect ;
    rdfs:label "Negligible Lethality (1.7 percent)" .

:Lethality18Percent rdf:type :SideEffect ;
    rdfs:label "Lethality (18 percent)" .

:RecoveryRate25Percent rdf:type :Symptom ;
    rdfs:label "Recovery Rate (25 percent)" .

:RecoveryRate40Percent rdf:type :Symptom ;
    rdfs:label "Recovery Rate (40 percent)" .

:N2CyanoethyleneUrea rdf:type :Molecule ;
    rdfs:label "N-(2-cyanoethylene)-urea" .

:ImmunoStimulationPathway rdf:type :Pathway ;
    rdfs:label "Immuno Stimulation Pathway" .

:CancerTreatmentPathway rdf:type :Pathway ;
    rdfs:label "Cancer Treatment Pathway" .

:TumorInhibitionPathway rdf:type :Pathway ;
    rdfs:label "Tumor Inhibition Pathway" .

:LeucocyteGene rdf:type :Gene ;
    rdfs:label "Leucocyte Gene" .

:TumorInhibitionMechanism rdf:type :Pathway ;
    rdfs:label "Tumor Inhibition Mechanism" .